Where the volume already is
Primary-care institutions handle 1.34 billion visits a year — 34.9% of all outpatient volume in China. Secondary hospitals handle 2.06 billion (53.6%); tertiary hospitals just 440 million (11.5%).

Primary-care institutions handle 1.34 billion visits a year — 34.9% of all outpatient volume in China. Secondary hospitals handle 2.06 billion (53.6%); tertiary hospitals just 440 million (11.5%).
Tiered diagnosis and treatment (分级诊疗) is national policy. Government projections place up to 80% of future healthcare growth at the primary-care level.
China has roughly 700,000 primary-care institutions spread across 2,840 counties. They are small, numerous and dispersed. Conventional field-force outreach does not scale here — the cost per physician contact is prohibitive.
Primary-care physicians carry the widest clinical remit with the least support. Demand for standardised clinical knowledge and current guidelines far exceeds supply.
Reach is not the same as depth. 80% of our physician network practises in tier-3 cities and below.
Women's health education across the life course, delivered to grassroots physicians.
Physician training delivered through our continuing-education system.
[TBD] 合作类型确认后撰写,事实包 §2;确认前用 A commercial partnership on medical education.(待用户核实此表述可用)
You provide the content and define the target physician profile — by province, institution type or clinical specialty.
Our medical team reviews every item for clinical accuracy and local applicability. We are a designated training provider for National Health Commission programmes, and our review process is built to that standard.
Approved content enters our continuing-education system and AI assistant layer, reaching physicians across all four channels. Our education model runs a full loop: baseline assessment → training → examination → certification.
You receive a partner account to track reach, engagement and certification — and export the data.
This is not a pilot process. We have run it for:
Adverse event reporting, built in. We manage long-term patient follow-up and adverse event reporting to the standards international pharmaceutical partners require. Compliance is not something we retrofit at the end of a programme.



A named account for your organisation, scoped to the content you funded. No waiting for a quarterly PDF.
Province → city → county → institution. See exactly where engagement is strong and where it is not.
We track 100% of physician content shares and the resulting resident clicks. You see not just whether a doctor completed a module, but whether the knowledge travelled to the community.
A physician counts as certified only after completing every course and passing every exam. Opening a page does not count.
Excel with institutional summary and individual detail — ready to drop into your internal reporting.
Why our numbers survive audit
Certification is derived from completion and examination records, not page views.
Village clinics roll up to their parent township health centre automatically, so institutional counts reflect the real administrative hierarchy.
Metrics are aggregated and de-identified. We do not expose individual patient data.
[TBD] 学情报告后台截图(脱敏打码),阻塞项 B7
Guideline Q&A. Retrieval over a curated corpus of clinical guidelines, answering with source-level citations.
Documentation assistant. Helps physicians complete forms and reports.
Population health assistant. Patient rosters, cohorts, follow-up scheduling and education materials.
Document analysis. Upload a document, ask questions against it.
Usage analytics. Query hit-rate trends and out-of-corpus question lists — a direct signal of where content is missing, feeding the next round of content planning.
Behind every answer sits a curated knowledge base with an authoritative, human-reviewed layer of [TBD] 章节数,待确认可披露口径 chapters. Automated monitoring watches authoritative sources for updates; nothing enters production without editorial approval.
AI-embedded content is limited to disease education, clinical guidelines and care standards. No branded drug recommendations. No product-oriented content. Everything passes academic review first.
Backed by a strategic partnership with JD Health since 2021 and working relationships with 100+ upstream device, diagnostics and pharmaceutical companies, we support sourcing and distribution links for overseas partners — whether you are sourcing medical devices, consumables or consumer health products from China, or bringing a brand into China's primary-care channel. [TBD] 可披露的品类与履约能力口径
Regulatory registration in the destination market remains the importer's responsibility.
Our in-platform marketplace spans five categories: medical AI models, AI agents, TCM diagnostic hardware, health devices and pharmaceuticals. We do not grant exclusivity to any single partner — vertical AI integration slots are open by design.
Grassroots physicians can consult top-tier specialists in real time on complex cases. For partners running disease-area programmes, this means education does not stop at knowledge transfer — it connects to an actual referral and consultation pathway.
| Credential | Note |
|---|---|
| Internet Hospital Licence | Operating licence for online medical services |
| Medical Institution Practice Licence | — |
| Medical Device Distribution Licence (Class III) | Highest risk class under Chinese regulation |
| Pharmaceutical Distribution Licence | — |
| ISO 9001 | Quality management system |
| Information Security Management System Certification | — |
| MLPS Filing | China's Multi-Level Protection Scheme for information systems |
We are a designated training provider for National Health Commission education programmes. Certificates in traditional Chinese medicine techniques, rehabilitation and health management are issued jointly with:
China Academy of Chinese Medical Sciences
Institute of Basic Theory for Chinese Medicine
World Federation of Acupuncture-Moxibustion Societies (exchange centre)
Partner dashboards show aggregated, de-identified engagement metrics only.
Raw clinical and patient data never leaves our domestic environment.
Content published through our AI layer is limited to disease education, clinical guidelines and treatment standards. We do not carry brand-directed product messaging.
Operating since 2016. Partners include AstraZeneca, Roche, JD Health and [TBD] 其余可披露的合作方名单,需用户确认哪些可列
Tell us what you want to achieve in China.
We reply within two business days.